Post My Press Release

Free Press Release Distribution

Author: pooja (Page 1 of 221)

Transplantation Therapeutics Market Size, Status and Forecast 2026

Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. In case of end-state organ failure, such as liver and heart failure, organ transplantation is often the only treatment. A significant upward trend has been observed in the last two years in the transplantation therapeutics market.

Factors driving the transplantation therapeutics market are rising non-communicable diseases, aging population and increasing life expectancy, growing income, rising government expenditure on health care, free trade agreement, and continuous research and development. According to Global Observatory on Donation and Transplantation, in 2015, around 126,670 solid organs, such as kidney, heart, liver, lungs, small bowel, and pancreas transplantations were performed worldwide, which is an increase of 5.8% since 2014. Kidney and the liver transplants are the widely performed transplant procedures.

Continuous research and development to provide innovative drugs and treatment for a host of diseases has boosted the development of the transplantation therapeutics. Technological innovation provided key players with the opportunity to penetrate a new therapeutic area/market. Moreover, rising number of prevalence and incidences of various diseases has increased the demand for highly innovative and better outcome products.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46386

Developing global economic conditions create lucrative opportunities for the expansion of the transplantation therapeutics market. Rise in individual per capita income boosts health care expenditure. In the developing countries of Asia Pacific and the Middle East, growing population and per capita income are important drivers of the market. According to the Economist Intelligence Unit (EIU), the number of high-income households is estimated to be around 540 million by 2019, out of which, Asia Pacific is likely to constitute a share of more than 50%.

Along with growing geriatric population and life expectancy rate, other factors, such as, increase in the number of stem cell donors, decline in infant mortality, enhanced living conditions, improved sanitation, and better prevention of communicable diseases are also projected to contribute to the advancement of the market. Although there are a number of drug options available in the market for acute rejections, long-term treatment options remain unsatisfactory. Risk of infection limits the effectiveness of these therapies. As such, improvement in their efficacy is needed.

The global transplantation therapeutics market can be segmented based on drug class, route of administration, distribution channel, and geography. In terms of drug class, the market can be categorized into antibody therapies, calcineurin inhibitors, anti-proliferative agents, mTor inhibitors, corticosteroids, and others. Based on distribution channel, the transplantation therapeutics market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. The online pharmacies segment is anticipated to record a significant growth during the forecast period, owing to factors, such as, ease of access to product comparison and discounts offered online.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46386

Region-wise, the global transplantation therapeutics market can be segmented into North America (NA), Europe, Asia Pacific (APAC), Latin America (LA), and Middle East & Africa (MEA). North America and Europe lead the global transplantation therapeutics market due to easy technological applications, funding and high income population in these regions. The other favorable reasons are high prevalence of lymphoproliferative disorders and leukemia, demand for better treatment options, and easy accessibility and acceptance of new technologies.

Transplantation rate in high income countries is increasing at a rapid pace, and continued rise is also seen in low income countries and is expected to grow further. The transplantation therapeutics pipeline comprises around 120 drug candidates in different stages of development. The pipeline consists of a high number of small molecules, biologics, and other drug candidates developed as peptides and protein. Companies are targeting a wide range of therapeutics, such as chemokine receptors, integrins, cadherins, and protein kinase. However, no particular class of target appears predominating in terms of pipeline volume.

Leading players operating in the global transplantation therapeutics market are Novartis AG, GlaxoSmithKline Plc, AbbVie Inc, Pfizer Inc, Astellas Pharma Inc, Gilead Sciences Inc, Quark Pharmaceuticals Inc, Takeda Pharmaceutical Company Ltd, Sanofi, and Boehringer Ingelheim.

Bioprocess Instruments and Consumables Market – Current Scenario and Future Growth Analysis by 2026

Bioprocess is defined as a technique used to produce biological products such as genetically microbial strains, commercially useful chemicals, etc.. Increase in interest in life science areas such as pharmacology & toxicology and biotechnology for the development of advanced medicines and vaccines has created a need for advanced bioprocess technology.

The global bioprocess instruments and consumables market is driven by expansion in the biopharmaceutical industry, , technological advancements, increase in demand for vaccines, and rise in the number of new drug launches. On the other hand, limited adherence of biological product development and shift toward stratified medicine are likely to restrain the global bioprocess technology market during the forecast period.

In 2017, the FDA approved five biosimilars products for several indications such as Renflexis (May 2017), Cyltezo (August 2017), Mvasi (September 2017), Ogivri (December 2017), and Ixifi (December 2017). In 2018, two biosimilars products have been approved by the U.S. FDA: Retacrit (May 2018) and Fulphila (2018). Increase in approvals of biosimilars in the U.S. and stainless steel facilities for large-scale commercial use are anticipated to provide expansion opportunities to the global bioprocess technology market during the forecast period.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46431

By product, the global bioprocess instruments and consumables market is segmented by Instruments and consumables and accessories. Furthermore, the global bioprocess instruments and consumables market is classified into bioprocess analyzers, blood gas analyzers, osmometers, bioreactors, incubators, cell counter systems and others (mass spectroscopy, centrifugation, filtration etc.). On the other hand, the global bioprocess instruments and consumables market is categorized into culture media, reagents and others.

In terms of application, the global bioprocess instruments and consumables market can be divided into antibiotics, recombinant proteins, biosimilars, and others. Based on end-user, the global bioprocess instruments and consumables market can be segmented into biopharmaceutical companies, contract manufacturing organizations, academic research institutes, food and feed industry, contract research organization, and others.

In terms of region, the global bioprocess instruments and consumables market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global bioprocess instruments and consumables market in 2017, accounting for a major market share. The expansion of the bioprocess instruments and consumables market in North America is fuelled by the availability of advanced technology and undertaking of a large number of research studies in the U.S.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46431

Europe is estimated to account for a significant market share in 2017.The market in the region is anticipated to expand at a significant growth rate during the forecast period. The market in Europe is driven by the expansion of the biopharmaceutical industry in the region; rise in demand for different products such as antibiotics, bio-similars, monoclonal antibodies, and recombinant proteins; and cost reductions of these products. The bioprocess instruments and accessories market in Asia Pacific is anticipated to expand at a rapid rate during the forecast period. High competition, increase in R&D expenditure of pharmaceutical and biotechnology companies, and shift of contract research organizations toward Asia Pacific are fuelling the bioprocess technology market in Asia Pacific.

The bioprocess instruments and consumables market in Latin America is estimated to constitute a key market share. The market in the region is likely to expand at a significant rate during the forecast period. Latin America, particularly Brazil, is a promising destination for the bioprocess technology market. Rise in prevalence of diseases, demand for antibiotics and vaccines, development of biosimilars, and partnership among institutional private players are likely to boost the bioprocess technology market in Latin America during the forecast period. On the other hand, the underdeveloped bioprocess industry, low presence of key vendors, and unaffordability of expensive instruments are likely to hamper the expansion of the bioprocess instruments and consumables market in Middle East & Africa during the forecast period.

Key companies operating in the global bioprocess instruments and accessories market are Thermo Fisher Scientific, Inc, Sartorius AG, Roche, GE Healthcare, Danaher, Nova Biomedical, Advanced Instruments, Inc., Lonza, Becton, Dickinson and Company, and Siemens Healthneers and others.

Sterilization Containers Market to Witness Comprehensive Growth by 2026

Sterilization containers are rigid reusable systems used to store and protect surgical instruments post sterilization. Rigid containers come in various materials and sizes and have filters to permit sterilizing agents to enter the container. Rigid containers are an alternative to pouches and wraps commonly used to package surgical instruments. They offer substantial environmental and economic benefits along with improved safety. They are categorized as Class II medical devices, and validation with different sterilization techniques is required.

Obtain Report Details @ https://www.transparencymarketresearch.com/sterilization-containers-market.html

Sterilization containers, which require higher upfront costs, are made of metal or plastic. With respect to lifespan, these containers last for years. Reusability of rigid containers leads to massive reduction in waste generated compare to sterilization wraps and their related disposal cost. As per an article published in 2012 by Practice Greenhealth, Mills-Peninsula Medical Centre, disposal processing was estimated at around 8-10 torn wrap sets per week costing the organization between $800 to $1000 per week and around $45,000 annually.

Sterilization wraps are less costly at first but generate 5% to 10% of total hospital waste. Significant disposal cost and damage to the environment are major concerns associated with wraps. This is boosting the adoption of rigid containers. For instance, the American Hospital Association published an article ‘Convert to Rigid Reusable Sterilization Containers’ that mentions that switching from disposable blue wrap to rigid reusable sterilization containers saves substantial amounts of money, reduces waste, decreases energy requirements, increases storage space, improves patient safety and instrument reprocessing turnaround time, and has been demonstrated to help health care organizations’ bottom line.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47634

Although the initial expenses of sterilization wraps are significantly lower, sterilization containers are much more cost-effective due to the fact that they are reusable and do not incur any cost related to waste disposable. Also, sterilization containers provide significant environmental benefits as they do not cause any medical waste.

Rise in use of rigid containers has permitted big medical device players to explore new avenues of profits. Therefore, the threat of new entrants is high to moderate for the sterilization containers market. Large medical device companies are entering the sterilization containers market and strengthening their business by developing advanced devices and new product launches. For instance, in 2016, Becton, Dickinson and Company introduced a new low temperature sterilization container, Genesis low temperature rigid container system, which is validated for newer low-temperature sterilization processes and systems from market-leading sterilizer manufacturers, including the V-PRO Low Temperature Sterilization Systems from STERIS and STERRAD Systems.

The global sterilization containers market can be segmented based on type, end-user, and geography. In terms of type, the sterilization containers market can be divided into perforated and non-perforated sterilization containers. Based on end-user, the sterilization containers market can be categorized into hospitals, ambulatory surgical centres, specialty clinics, and others. The hospitals segment is expected to boost the global sterilization containers market due to high demand for sterilization products in operation rooms of hospitals globally.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=47634

In terms of geography, the global sterilization containers market can be segmented into.  North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Roughly 60% of hospitals in Europe use rigid containers and the remaining 40% use blue wraps. Europe is expected to hold a major share in the sterilization containers market during the forecast period owing to environmental awareness and adoption of strict policies to control ecological deterioration.

The sterilization containers market in North America expected to expand at a rapid CAGR during forecast period due to changing trend of adoption of containers over wraps. The market in Asia Pacific and Latin America is anticipated to expand in future due to low environmental awareness, rise in health care spending, and improving health care infrastructure. High upfront cost of rigid containers compared to wraps is one of the major factors limiting the expansion of the sterilization containers market in rapidly developing countries such as China, India, Brazil, etc..

The rivalry in the global sterilization containers market is high to moderate. The sterilization containers market is consolidated in nature with a few large players holding substantial market share. Aesculap, Inc., a subsidiary of B. Braun Company, holds a major share and is considered to be the market leader in the global sterilization containers market. Major market players in the global sterilization containers market include Case Medical, Becton, Dickinson and Company, Aygun Co. Inc., Jewel Precision, Paragon Medical, Medline Industries, Inc. and Symmetry Surgical Inc.

Plasma Freezers Market Estimated to Flourish by 2026

Plasma freezers are designed to maintain temperatures in the range of -30°C to -40°C. These freezers are used in blood banks, research institutes, pharmacies, and hospital plasma freezers for the storage of plasma products, whole blood, vaccines, and test samples. The plasma freezers market is anticipated to dominate the biomedical freezers industry during the forecast period. This is primarily attributed to the increase in number of apheresis procedures and rise in demand for the storage of fresh frozen plasma (FFP).

According to the American Society for Apheresis (ASFA), plasma exchange is the most common apheresis procedure in the U.S. In addition, many key players are offering varieties of plasma freezers to customers. For example, Labcold offers various certified plasma freezers (in accordance with European Union Directive 93/42/EEC) such as Bench Top RVPF0234MD, Floor Standing RVPF0734MD, Freestanding RVPF1334MD, and Free Standing RVPF2134MD. This is expected to boost use of plasma freezers by end-users such as blood banks and hospitals, driving the plasma freezers market.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46398

Technological advancements have brought about a paradigm shift from the usage of traditional equipment to advanced technology-based equipment that offer efficient energy consumption. Plasma freezers with new technologies effectively reduce energy consumption, prevent crystallization, and minimize uneven temperature distribution. Companies such as Thermo Fisher Scientific, Eppendorf AG, Philipp Kirsch GmbH, and Panasonic Biomedical are engaged in the development of technologically advanced biomedical refrigerators and freezers.

For example, in September 2013, Panasonic Biomedical introduced new cost-efficient -30?C freezers featuring inverter technology. This new technology helps in reducing energy consumption and enhances temperature stability within the chamber. Introduction of these new technologies is expected to result in high adoption rates, which, in turn, is anticipated to drive the market during the forecast period. Manufacturers are now channelizing their funds into research and development in order to introduce cost-effective and sophisticated refrigerators and freezers. For instance, in 2013, Thermo Fisher Scientific invested around US$ 396 Mn (up US$ 20 Mn as compared to 2012) in research and development to introduce innovative products. Increase in research and development activities by key companies is likely to lead to the introduction of new technologies in the near future. These factors are likely to increase acceptance and adoption of biomedical refrigerators and freezers, thereby driving the expansion of the plasma freezers market.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46398

The global plasma freezers market can be segmented based on type, end-user, and geography. Based on type, the plasma freezers market can be divided into upright, built-in, and chest plasma freezers. In terms of end-user, the plasma freezers market can be categorized into hospitals, research laboratories, pharmacies, diagnostic centers, blood banks, and others. Laboratory refrigerators and laboratory freezers are widely used in hospital settings to preserve pharmaceutical drugs, medical supplies, and biological samples. This is projected to propel the global plasma freezers market.

In terms of geography, the plasma freezers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to hold a major share of the global plasma freezers market during the forecast period owing to highly developed health care infrastructure, presence of a large number of R&D institutes, and high adoption rate of advanced technologies. The market in Asia Pacific and Latin America is are expected to expand in the future due to rise in health care spending and improving health care infrastructure. Major players in the global plasma freezers market include Thermo Fisher Scientific Inc., Panasonic Healthcare Co. Ltd., Eppendorf AG, Philipp Kirsch GmbH, Haier Biomedical, and Helmer Scientificetc.

Stem Cell Banking Market : Review with Forecast Research Report 2018–2026

The stem cell banking is the practice of preserving blood cell from a new born baby for future use. The preserved blood is used in medical therapies for a variety of diseases, which include conditions such as sarcoma, leukemia, immune conditions, lymphoma, and metabolic disorders. Stem cells are capable of producing blood cells, namely red blood cells, platelets, and white blood cells, which are produced in the human body. Researchers have discovered that stem cells can be used for the treatment of 80 different diseases including thalassemia, sickle cell anemia, leukemia, diabetes, and cardiac diseases.

Obtain Report Details @ https://www.transparencymarketresearch.com/stem-cell-banking-market.html

The major sources for stem cell bank are storing of peripheral blood and bone marrow, umbilical cord blood (UCB) is by far considered as the largest component for hematopoietic stem cells. In the past few years, donated umbilical cord blood has become a reliable source of stem cells, and is thus considered as a valuable biological resource. The chances of cord blood sample matching with the patients that is closely in relation to the baby whose sample is to be used are 39% more than the sample obtained from the public banks. Stem cell banking services is a promising and fast growing segment in the field of next generation stem cell therapy and national cord blood registries are changing perception and look of the industry.

Rise in incidence of chronic conditions and increase in investments by pharmaceutical and biopharmaceutical companies for stem cell research are expected to drive the global stem cell banking market during the forecast period. Rise in the number of stem cell donors and superior quality of stem cell banking facilities and increase in research & development are expected to drive the global stem cells market. However, high processing & storage cost and lack of acceptance and awareness in developing regions are likely to inhibit the market.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46320

The global stem cell banking market can be segmented based on source, service type, application, end-user, and geography. In terms of source, the stem cell banking market can be categorized into placental stem cells, adipose tissue-derived stem cells, bone marrow-derived stem cells, human embryo-derived stem cells, dental pulp-derived stem cells, and others. Based on service type, the stem cell banking market can be divided into sample preservation and storage, sample analysis, sample processing, and sample collection & transportation. In terms of application, the stem cell banking market can be classified into research applications, clinical applications, and others. Based on end-user, the global stem cell banking market can be segmented into hospitals (medical applications), pharmaceutical research (drug discovery), research institutes (scientific research), and others.

In terms of region, the global stem cell banking market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of revenue, North America dominated the stem cell banking market in 2017, followed by Europe. North America dominated the global market due to increasing prevalence of chronic diseases and expanding network of stem cell banking services. The market in Asia Pacific, Latin America, and Middle East & Africa is anticipated to expand at a high growth during the forecast period due to growth in the health care industry and increase in patient population in these regions. The market in China, Brazil, and India is projected to expand at a considerable pace between 2018 and 2026 due to rise in investment by governments of these countries to improve health care facilities.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46320

Key players operating in the global stem cell banking market include Cord Blood Registry (CBR) Systems, Inc., Cryo-Cell International, Inc. Cordlife Group Limited, Lifecell International Private Limited, Cryo-Save AG, and StemCyte.

Human Liver Models Market Insights and Emerging Trends by 2026

Liver is a vital organ that performs several important bodily functions including bile production for digestion, protein production, synthesis of blood clotting factors, storage of glucose (sugar) in the form glycogen, and detoxification. Also, the liver cells have a remarkable ability to regenerate themselves after any damage. Due to this unique capability, the liver tissues have fascinated the researchers. True understanding of molecular and cellular connectivity and functions of the liver tissues in an in-vivo as well as in-vitro setting is very important from the viewpoint of discovery science and clinical application.

Obtain Report Details @ https://www.transparencymarketresearch.com/human-liver-models-market.html

Development of liver models that can provide a virtual ecosystem that mimics the molecular processes of a liver factory can help understand molecular interactions to network dynamics and whole organ functions. These advanced liver models are mini-organs or organoids that are expected to replicate human liver physiology, anatomy, and functions from molecular layer upward. The formation of these living models is a fairly new area of science that has the potential to replace animal models. The human liver models offer several advantages over animal models that are not always accurate and pose ethical issues. The human liver models or organoids have been used to screen new drugs for liver toxicity. These models are also being deeply studied to build a functional model of human liver development.

The process of making a human liver model starts with a fetal liver progenitor cell, an immature cell that transforms into a specialized liver cell. The fetal liver progenitor cell is allowed to self-assemble in a small disc. These discs are composed of ferret liver cells that are pre-processed to remove all cells of the ferret. The resultant mini-organ models the actual human liver development. These models have been observed to generate hepatocytes, the basic functional cells of the liver, which is expected to produce the functional bioengineered liver tissues for transplantation into patients in the near future.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46506

The global human liver models market can be segmented based on platform type and region. In terms of platform type, the market can segmented into liver organoids, animal models, 2D models, liver-on-a-chip, and 3D bio-printed models. As animal models are crucial for studying the disease progression in humans, the demand for animal models is expected to increase during the forecast period.

However, liver-on-a-chip offers a simpler and inexpensive alternative for animal model and it is expected to be a rapidly expanding segment during the forecast period. Rising demand for developing substitutes for animal testing models, increasing prevalence of fatty liver disease, growing funding for research and development, and surging necessity for early detection of drug toxicity to minimize late-stage drug failure are some of the factors anticipated to drive the global human liver models market during the forecast period.

Based on region, the global human liver models market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for a prominent share of the market from 2018 to 2026, due to high expenditure on health care R&D, high adoption of innovative potential therapies, and introduction of technologically advanced products in these regions.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46506

The human liver models market in Asia Pacific is expected to expand at a significant rate during the forecast period, owing to increase in R&D funding in developing countries in the region. Key factors driving the global human liver models market are rapid development of health care infrastructure and high focus on research and development in the health care sector.

Some of the key players operating in the global human liver models market are Mimetas, InSphero, Organovo Holdings Inc., Ascendance Biotechnology, Emulate, Inc., CN Bio, and Cyfuse Biomedical.

Cell and Tissue Culture Supplies Market to Be at Forefront by 2023

Cell and Tissue Culture Supplies Market: Snapshot

Cell and tissue culture is a process to eliminate cells and tissues from an animal or a plant, and later grow them in an artificially created environment, known as cultivation, with controlled nutrition, temperature, and humidity conditions. In past few decades owing to continuous advancements, cell culture has become one of the major tools in cellular and molecular biology for example, effects of toxins and various drugs on cells, physiology, carcinogenesis of cells, and biochemistry, mutagenesis. The benefit of their property to obtain efficient results from the use of a segment of cultured cells continues to prompt the rising use of cell and tissue culture for such applications.

The global market for cell and tissue culture supplies is segmented on the basis of culture systems, instruments as cryostorage equipment, biosafety cabinets, incubators, roller bottle equipment, and pipetting instruments. The culture systems segment is further categorized into multiple well plates, roller bottles, culture dishes, culture bags, tissue culture flasks, and bioreactors. On the basis of type, the global market is segregated into cell and tissue culture systems, cell and tissue culture cylinders, bioreactors, petri dishes, cell and tissue spreaders and lifters, roller bottle culture apparatus, cell and tissue culture cylinders, tissue grinders for cell and tissue culture, cell and tissue spreaders, serological pipettes, and so on.

Cell and Tissue Culture Supplies Market

The global market of cell and tissue supplies is mainly supported by the rising demand for artificial biopharmaceutical products and organs over the globe. The significant growth in importance of cell culture advancements in the fields of research and development of wide range of bimolecular and therapeutics components is further boosting the overall demand for cell and tissue supplies. The major end users of cell and tissue supplies comprise business cell culture labs, biotechnology organizations, and pharmaceutical organizations.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4503

Apart from that, the market is profiting by the upgradation in specialty growth media and culture procedures, which guarantee accessibility and specificity of advanced technology for scaling up cultures. In any case, ethical issues over the utilization of animals sources for cell culture is anticipated to hinder the scope of development of the market to a certain degree in upcoming years.

Cell and Tissue Culture Supplies Market

On the basis of geography, the global cell and tissue supplies market is dominated by North America. The reign of the region in this sector is credited to the rise in advancements in technologies in cell culture tools in the last few years. Moreover, the rise in surge for animal component-free media and the rise in demand for automated cell culture systems is foreseen to further boost the demand for cell culture supplies in North America. Europe is also one of the leading consumers of cell and tissue culture supplies because of high focus on pharmaceutical and biotechnology companies and cell culture researchers in the region. However, Asia-Pacific is expected to emerge as one of the promising regional market for cell and tissue suppliers during the forecast period.

Expanding Operations In Future? To Get The Perfect Launch Ask For A Custom Report Here

Cell and Tissue Culture Supplies Market

STEMCELL Technologies, Sigma-Aldrich Co. LLC., Capitol Scientific, Inc., Wheaton Industries, Biocompare, Inc., VWR International, LLC, and GE Healthcare Ltd. are among the major palyers dominating the global cell and tissue culture market.

Animal Workstations Market Size to Observe Steady Growth

Laboratory animals play a major part in medical research centers and laboratories. Animals can contract allergic reactions, which can have a negative impact on the health of workers and people handling the animals. During the cage changing process, workers come in direct contact with by products and wastes of animals, which can induce respiratory and other disorders in the workers. Thus, animal workstations are used to establish safe and laboratory practices to protect the laboratory environment from allergens caused by these animals. Animal workstation is a system, wherein non-turbulent and uniform air-flow prevents cross-contamination of allergens in the work area. Various filters are employed in the system to ensure that the down flow of air is free from contaminants and cleans the exhausting air.

Obtain Report Details @ https://www.transparencymarketresearch.com/animal-workstations-market.html

Rise in concerns about the safety of health care workers, increase in incidence rate of animal-induced asthma, and introduction of dual access animal workstations are key factors that are expected to propel the animal workstations market during the forecast period. However, lack of awareness about technological advancements in laboratory safety equipment is anticipated to restrain the animal workstations market by 2026.

The global animal workstations market is segmented based on equipment type, technology, end-user, and region. In terms of equipment type, the global animal workstations market is categorized into dual access workstation, bedding disposal workstation, and single-sided workstation. Dual access workstation accounted for a considerable share of the market in 2017, as it has 3 filters in the system which efficiently filter the contaminated air and the activated carbon in the filters removes odour.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46350

The segment is expected to continue its dominance during the forecast period in terms of revenue. Based on end-user, the global animal workstations market is segmented into veterinary hospitals, veterinary clinics, research laboratories, academic institutes, pharmaceutical companies, and others. In terms of revenue, the research laboratories segment dominated the market in 2017, due to rise in research grants and funding by governments to promote research on novel veterinary therapies.

The pharmaceutical companies segment is anticipated to expand at a significant CAGR by 2026 due to improvements in the pharmaceutical industry in emerging economies. Based on technology, the animal workstations market is categorized into vented workstations, anesthetic workstations, microscope workstations, and others. The anesthetic workstation segment is anticipated to expand at a considerable CAGR during the forecast period due to the rise in usage of anesthesia to perform operating procedures on animals. This segment accounted for the largest share of the market in terms of revenue in 2017, and is expected to continue this trend during the forecast period.

In terms of geography, the global animal workstations market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the market in 2017 which is attributed to the rising adoption rate of animal workstations by veterinarians for technological advancements in the animal laboratory equipment, and increase in incidence rate of animal induced disorders such as respiratory diseases among workers.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46350

Emergence of regional manufacturers is expected to propel the animal workstations market in Europe. The market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period due to rise in penetration of key manufacturers in the countries such as China and India, increase in research activities in emerging countries of Asia Pacific, and expansion of the pharmaceutical sector in India.

Key players operating in the animal workstations market include Colcom Inc., LABREPCO, Hallowell Engineering & Manufacturing Corporation., ACOMA Medical Industry Co., Ltd, Smiths Medical, NuAire, Mortech Manufacturing Company Inc., Fisher Scientific International, Inc., Esco Micro Pte Ltd., Geneva Scientific, Midmark Corp, DRE Veterinary, and others.

Page 1 of 221

Powered by WordPress & Theme by Anders Norén